drugset / Trial / NCT00487461
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to test whether treatment with a drug called Simvastatin prevents and improves outcome in patients who have Subarachnoid bleeding. Simvastatin is currently approved for the treatment of high cholesterol levels.
Timeline
- Start
- 2007-05
- Primary completion
- 2009-02
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | Oral |
| Subject | Simvastatin | Small molecule | 80 mg | Oral |